تحميل
HKSEHealthcareBiotechnology
أحدث البيانات المتاحة
5.31 HK$
−0.15 HK$ · -2.75%
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
أحدث البيانات المتاحة
5.31 HK$
−0.15 HK$ · -2.75%
تستخدم الأوقات اليومية المنطقة الزمنية HKT. قد تتأخر بيانات السوق.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
نطاق اليوم
السعر الحالي 5.31 HK$
نطاق 52 أسبوعًا
السعر الحالي 5.31 HK$
تستخدم الأوقات اليومية المنطقة الزمنية HKT. قد تتأخر بيانات السوق.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
نطاق اليوم
السعر الحالي 5.31 HK$
نطاق 52 أسبوعًا
السعر الحالي 5.31 HK$
| الإجراء | تاريخ الاستحقاق | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
توزيعات الأرباح | 17 يونيو 2026 | 0.0655 HK$Annual | 18 يونيو 2026 | 30 يوليو 2026 |
توزيعات الأرباح | 13 يونيو 2025 | 0.061 HK$Annual | 16 يونيو 2025 | 30 يوليو 2025 |
استحقاق التوزيعات 17 يونيو 2026
0.0655 HK$
Annual
تاريخ التسجيل 18 يونيو 2026 · تاريخ الدفع 30 يوليو 2026
استحقاق التوزيعات 13 يونيو 2025
0.061 HK$
Annual
تاريخ التسجيل 16 يونيو 2025 · تاريخ الدفع 30 يوليو 2025
2359.HK
WuXi AppTec Co., Ltd.
218.4 HK$
-0.09%
1276.HK
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
49.14 HK$
+1.53%
6160.HK
BeOne Medicines AG
217 HK$
-1.63%
2269.HK
WuXi Biologics (Cayman) Inc.
56.70 HK$
-2.07%
3692.HK
Hansoh Pharmaceutical Group Company Limited
33.92 HK$
-1.97%
1801.HK
Innovent Biologics, Inc.
97.50 HK$
-1.86%
المحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.